Progression Suppression and Retinal Regression in VEGF-resistant AMD

NCT07005323 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PharmaBio Corporation